<DOC>
	<DOCNO>NCT00301080</DOCNO>
	<brief_summary>D-cycloserine may help lessen pain symptom peripheral neuropathy cause chemotherapy . It yet know whether D-cycloserine effective placebo treat peripheral neuropathy cause chemotherapy . This randomized , double-blind , placebo-controlled clinical trial design study D-cycloserine 2 different dos see well work compare placebo treat cancer patient peripheral neuropathy cause chemotherapy .</brief_summary>
	<brief_title>D-cycloserine Management Chemotherapy-Induced Peripheral Neuropathic Pain</brief_title>
	<detailed_description>This randomize , double-blind , placebo-controlled study . Initially , patient randomize 1 2 treatment arm ( D-cycloserine 250 mg twice daily placebo twice daily ) , treat 4 week absence unacceptable toxicity . Later , design change randomize patient 1 3 arm follow : - D-cycloserine 50 mg twice daily 12 week - D-cycloserine 200 mg twice daily 12 week - Placebo twice daily 12 week</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Neurotoxicity Syndromes</mesh_term>
	<mesh_term>Cycloserine</mesh_term>
	<criteria>Patients least 18 year age . Patients experience moderate severe peripheral neuropathic pain Patients may chronic adjuvant pain medication antidepressant must stable dos least one week prior admission . Patients may take concurrent opioids must willing allow u monitor opioid use trial . Patients must chronic peripheral neuropathic pain define pain 3 month duration begin association chemotherapy . Patient 's bilateral peripheral neuropathic pain symptom primarily involve foot Patients must breast cancer ( stage ) Patients must able read speak English provide inform consent . Patients may receive chemotherapy long agent know cause peripheral neuropathy . Patients must ECOG Performance Status &lt; 3 able attend physician study visit Patients must concurrently use gabapentin pregabalin must willing wean anticonvulsant medication prior start trial . Patients may diabetes mellitus ( type 1 2 ) long preexist neuropathy . Exclusion criterion : Patients secondary cause neuropathic pain include : HIV/AIDS , traumatic injury , personal history non chemotherapyinduced neuropathy . Patients history major depression severe anxiety . Women childbearing age agree take measure prevent pregnancy breastfeed study medication . Women currently pregnant invite participate study . Patients history seizure . Patients currently receive antibiotic therapy tuberculosis ( e.g . isoniazid ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>pain</keyword>
	<keyword>neurotoxicity</keyword>
	<keyword>breast cancer</keyword>
</DOC>